Managed Markets
Network

Introducing a new FDA-approved therapy for relapsed/refractory AML | AJMC® is seeking submissions on the following clinical topics: Immunology, Oncology, Diabetes, Neurology, Infectious Diseases, and Respiratory Diseases. Submit your research today!

Journals

MORE >>>
Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients
August 16, 2018 – Paul Crits-Christoph, PhD; Robert Gallop, PhD; Elizabeth Noll, PhD; Aileen Rothbard, ScD; Caroline K. Diehl, BS; Mary Beth Connolly Gibbons, PhD; Robert Gross, MD, MSCE; and Karin V. Rhodes, MD, MS
Modeling the Impacts of Restrictive Formularies on Patients With HIV
July 13, 2018 – James Baumgardner, PhD; Caroline Huber, MPH; Mina Kabiri, PhD; Lara Yoon, MPH; Jacki Chou, MPP, MPL; and John Romley, PhD
Expert Panel: Access to Multiple Treatment Options Is Needed to Continue the Fight Against HIV
June 07, 2017 – Jerry Cade, MD; Jeff Dunn, PharmD, MBA; Holly Kilness-Packett, MA; Glen Pietrandoni, RPh, AAHIVP; Carl Schmid, MBA
ACCOUNTABLE CARE DELIVERY CONGRESS
CONTINUING EDUCATION
CONTRIBUTORS
MEETINGS
PARTICIPATE
COMPENDIA
In Focus Blog
Press Releases
Interactive Tools
Managed Care Podcast
Panel Discussions
Week In Review
Information for Reviewers
Information for Authors
Formulary Central
Clinical Study Summaries
Study Summaries
About Us
AJAC
AJMC
EBDM
EBO
AJMC Resources
Careers
Contact Us
Privacy Policy
Terms & Conditions
Subscribe
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!